U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Celebrity Inventors

Actor Zeppo Marx patented a "Cardiac Pulse Rate Monitor" in 1969.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 560/160 - Oxy in acid moiety


Subclass of Class 560 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the acid radical contains an -OX group
No. of applications: 35
Last issue date: 02/23/2012


Application No.Application TitleIssue Date
20120046484Monomers and Macromers for Forming Hydrogels
Disclosed are new compounds having utility in applications, including as reactants and intermediates in for the formation of polymers and polymeric materials especially useful as hydrogels for ophthalmic lenses....
02/23/2012
20120046478LIPID CONTAINING FORMULATIONS
Compositions and methods useful in administering nucleic acid based therapies, for example association complexes such as liposomes and lipoplexes are described....
02/23/2012
20120046293RENIN INHIBITORS
The present invention relates to renin inhibitor compounds having the structure

and their use in treating cardiovascular events and renal insufficiency....

02/23/2012
20120040993NEUROPROTECTIVE MULTIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
Multifunctional compounds are provided, comprising two or more functional moieties selected from: (i) a moiety that imparts an iron chelator function; (ii) a moiety that imparts a neuroprotective function; (iii) a moiety that imparts combined antiapoptotic, neuroprotect...
02/16/2012
201103131772-Oxo-1, 3-dioxolane-4-carboxylic Acid and Derivatives Thereof, Their Preparation and Use
2-Oxo-1,3-dioxolane-4-carboxylic acid and derivatives thereof, according to the following formula,

in which R1 represents a negative charge, hydrogen or may be methyl or ethyl or an n-valent radica...

12/22/2011
20110306600NOVEL THERAPEUTIC COMPOUNDS
The invention discloses a number of therapeutic compounds and a method of treating a disorder in mammal....
12/15/2011
20110269722PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS
The invention provides the compounds of formula (I) or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutical compositions comprising one or more compounds of formula I or intermediates thereof and one more of pharmaceutically acceptable c...
11/03/2011
20110237814NOVEL RUTHENIUM CARBONYL COMPLEX HAVING TRIDENTATE LIGAND, ITS PRODUCTION METHOD AND USE
The present invention relates to a ruthenium carbonyl complex that is represented by the following Formula (1):


RuXY(CO)(L)  (1)

  • 09/29/2011
20110223105NEW 5-AMINOLEVULINIC ACID PRODRUGS FOR USE IN PHOTODYNAMIC THERAPY AND PHOTODYNAMIC DIAGNOSIS
There is provided a compound of Formula

and salts thereof wherein

  • R1 is an imine or an alkylated imine, said imine or alkylate...
09/15/2011
20110223535PHOTORESIST COMPRISING NITROGEN-CONTAINING COMPOUND
New nitrogen-containing compounds are provided that comprise multiple hydroxyl moieties and photoresist compositions that comprise such nitrogen-containing compounds. Preferred nitrogen-containing compounds comprise 1) multiple hydroxyl substituents (i.e. 2 or more) and...
09/15/2011
20110218238COMPOUNDS, COMPOSITIONS, FORMULATIONS AND THEIR USES THEREOF
A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceu...
09/08/2011
20110200582LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided are compositions and uses for cationic lipid compounds of formula (I).

...
08/18/2011
20110160228DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION
The present invention relates to compounds of formula (I) below in which: —R1 and R3 represent, independently of one another, a methoxy group optionally substituted by one or more fluorine atoms, —R2 and R4 represent, inde...
06/30/2011
20110143622FLUORINATED ACRYLATE COMPOSITIONS
Disclosed are fluorinated acrylate compounds. The compounds are useful as monomers in the preparation of polymeric surfactants and additives for coating compositions or as treatment agents to impart various surface properties to substrates...
06/16/2011
20110130454PRODRUGS OF GAMMA-AMINO ACID, ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions of prodrugs of alpha-2-delta ligands, methods of making prodrugs of alpha-2-delta ligands, and methods of using prodrugs of alpha-2-delta ligands and pharmaceutical compositions of prodrugs of alpha-2-delta ...
06/02/2011
20110124705PRODRUGS OF ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions of prodrugs of alpha-2-delta ligands, methods of making prodrugs of alpha-2-delta ligands, and methods of using prodrugs of alpha-2-delta ligands and pharmaceutical compositions of prodrugs of alpha-2-delta ...
05/26/2011
20110118451COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a ...
05/19/2011
20110104057Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation
What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and their use....
05/05/2011
20110021761Segmented Polymers and Their Conjugates
Segmented water soluble polymers, containing a higher molecular weight segment linked to a lower molecular weight segment, are described. In one embodiment, the polymer segments are poly(ethylene glycol) segments. The segmented polymers are functionalized and are useful...
01/27/2011
20110014715Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application
This invention relates to a peptide nucleic acid (PNA) oligomer which is conjugated with one or more linear-type amino acid containing a plurality of alkyleneglycols and to a synthesis method thereof. In addition, this invention related to a linear amino acid spacer in ...
01/20/2011
20100290991NOVEL [F-18]-LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), THEIR USE AND PROCESSES FOR THEIR PREPARATION
What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and their use....
11/18/2010
20100196826Photoinitiators for Energy Curing
Photopolymerisable systems for coatings or photolithography comprising radically photopolimerisable oligomers and/or monomers having ethylenically unsaturated groups and, as photoinitiator, at least one compound of formula (I).

...

08/05/2010
20100113797METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE
This disclosure relates to methods for preparing an enantiomerically enriched N-carboxyanhydride of an amino alpha acid of the formula (IIIa) or (IIIb):

from a compound of the formula (IIa) or (IIb), respecti...

05/06/2010
20100063294ALCOHOL PRODUCTION METHOD BY REDUCING ESTER OF LACTONE WITH HYDROGEN
Provided is an alcohol production method comprising the step of reducing an ester or a lactone with hydrogen to produce a corresponding alcohol without addition of a base compound by using, as a catalyst, a ruthenium complex represented by the following general formula ...
03/11/2010
20090234138ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS
The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs th...
09/17/2009
20090186832AMINO ACID PEPTIDE PRO-DRUGS OF PHENOLIC ANALGESICS AND USES THEREOF
Prodrugs of meptazinol and other phenolic analgesics exhibiting low oral bioavailability with amino acids or lower peptides, pharmaceutical compositions containing such prodrugs and a method for providing pain relief with such prodrugs are provided. In addition, the pre...
07/23/2009
20090170917Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase
Among other things, the present invention provides novel compounds capable of effectively inhibiting inflammatory responses that are mediated by G-proteins or GPCRs in neutrophils, macrophages and platelets. In particular, compounds of the present invention act as inhib...
07/02/2009
20090018233Crosslink Agents and Dual Radical Cure Polymer
A synthetic route to polymers comprised of at least two monomers each with a very different reactivity ratio by using a corresponding crosslink agent for each monomer. Novel crosslink agents are described that provide for the copolymerization of at least one hydrophilic...
01/15/2009
20080312467NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO-PENTAN-1,5-DIOL
The present invention provides a novel method for preparing a key intermediate, 3-amino-pentan-1,5-diol (2), which is useful for the preparation of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)-propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidine-7-one (1) a MAP-k...
12/18/2008
20080306281NOVEL COMPOUNDS COMPRISING A THIOCARBONYL-SULFANYL GROUP WHICH CAN BE USED FOR THE RADICAL SYNTHESIS OF ALPHA-PERFLUOROALKYLAMINE COMPOUNDS
The invention relates to compounds having the general formula (I), the method of preparation thereof and the use thereof in organic radical synthesis. The invention also relates to compounds having the formula (II), the method of preparation thereof and a method for pre...
12/11/2008
20080207913Poly(ethylene glycol) containing chemically disparate endgroups
The present invention provides bifunctional polymers, methods of preparing the same, and intermediates thereto. These compounds are useful in a variety of applications including the PEGylation of biologically active molecules. The invention also provides methods of usin...
08/28/2008
20080167489Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth) acrylates
The invention relates to a process for producing carbamoyloxy(meth)acrylates which comprises transesterification of hydroxyalkyl carbamates with an (meth)acrylate of formula CH2═CR29—COOR30 wherein R29 is hydrogen or methy...
07/10/2008
20060217570Novel Tertiary Amine Compounds Having An Ester Structure And Processes For Preparing The Same
The present invention provides ester group-containing tertiary amine compounds of the formula (R1OCH2CH2)nN(CH2CH2CO2R2)3-n which, when used as additives in chemical ampli...
09/28/2006
20060089473Diol (meth) acrylate compound having urethane bond, method for producing the same, and polymer thereof
The present invention provides compounds having in their molecule a structure contributing to high hydrophilicity, and having high photopolymerizability, as well as polymers of such compounds, and a method for producing the compound. The compounds are diol (meth)acryla...
04/27/2006
20050054819Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
Cycloalkyl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such cycloalkyl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including...
03/10/2005
 
Sign InRegister
Username  
Password   
forgot password?